Neuland Laboratories is currently trading at Rs. 297.00, up by 0.90 points or 0.30% from its previous closing of Rs. 296.10 on the BSE.
The scrip opened at Rs. 300.00 and has touched a high and low of Rs. 304.00 and Rs. 296.40 respectively. So far 1209 shares were traded on the counter.
The BSE group 'B' stock of face value Rs. 10 has touched a 52 week high of Rs. 370.40 on 19-Dec-2013 and a 52 week low of Rs. 86.75 on 19-Mar-2013.
Last one week high and low of the scrip stood at Rs. 331.75 and Rs. 275.00 respectively. The current market cap of the company is Rs. 226.91 crore.
The promoters holding in the company stood at 50.07% while Institutions and Non-Institutions held 0.01% and 49.92% respectively.
Neuland Laboratories has reported results for third quarter ended December 31, 2013.
The company has reported more than two fold jump in its net profit at Rs 6.82 crore for the quarter, as compared to Rs 3.27 crore for the same quarter in the previous year. Total income from operations of the company increased by 22.49% at Rs 131.55 crore for quarter under review as compared to Rs 107.40 crore for the quarter ended December 31, 2012.
Neuland Laboratories is engaged in manufacturing of Salbutamol Sulphate. The company has two world-class API manufacturing facilities close to the city of Hyderabad, capable in handling complex and hazardous reactions.
Company Name | CMP |
---|---|
Sun Pharma Inds. | 1804.65 |
Dr. Reddys Lab | 1209.00 |
Cipla | 1503.40 |
Lupin | 2107.30 |
Zydus Lifesciences | 964.95 |
View more.. |